Skip to content

A Clinical Study to compare the effects of Grivabasti with Prasarini Taila and Baladi Kwath orally in patients suffering from uncomplicated Manyastambha(Cervical Spondylosis)

A Comparative Study of Prasarini Taila Grivabasti and Baladi Kwath in the management of uncomplicated Manyastambha (Cervical Spondylosis) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059559
Enrollment
60
Registered
2023-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M190- Primary osteoarthritis of other joints

Interventions

None listed

Sponsors

Dr Sabrina Yasmin Barbhuiya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients of either sex with presenting symptoms of cervical spondylosis and fulfilling the diagnostic criteria. •Age group between 18 years to 60 years. •Clinical symptoms with or without radiological.

Exclusion criteria

Exclusion criteria: •Stenosis of the spinal canal. •Cervical injury. •Myelopathy. •Autoimmune/ inflammatory diseases- Rheumatoid arthritis, SLE, Ankylosing spondylitis etc. •Any acute or chronic systemic disease. •Pregnant lady and lactating mother.

Design outcomes

Secondary

MeasureTime frame
Complete absence of presenting symptoms of Cervical SpondylosisTimepoint: 15th day, 30th day, 60th day, 90th day

Primary

MeasureTime frame
1.Relief in presenting symptoms of Cervical Spondylosis. 2.Improvement in Visual Analogue Scale(VAS) for pain. 3.Improvement in Neck Disability Index(NDI) Score and Disability level.Timepoint: 15th day, 30th day, 60th day, 90th day

Countries

India

Contacts

Public ContactDr Manir Uddin Dewan

Govt. Ayurvedic College and Hospital, Guwahati

sabrinayasmin1796@gmail.com8638177470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026